ArticleBioinformatics advances2026
DCGAT-DTI: dynamic cross-graph attention network for drug-target interaction prediction.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A Length-Adaptive LLM-Enhanced Method for Drug-Target Interaction Prediction.International journal of molecular sciences · 2026Article
- Graph-based contrastive learning enables unified integration and niche transfer across single-cell and spatial multi-omics.Briefings in bioinformatics · 2026Article
- AGCLD: an adaptive graph contrastive learning method with denoising for spatial domain identification.Briefings in bioinformatics · 2026Article
- CAGNet: a structure-aware clustering-alternated graph network for cell-cell interaction inference in spatial transcriptomics.BMC bioinformatics · 2026Article
- CME-KGDTI: integrating clustered mutations into knowledge graph embedding for drug-target interaction prediction.BioData mining · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Drug-target interaction (DTI) prediction accelerates drug discovery by identifying interactions between chemical compounds and proteins. Existing methods often rely on drug-drug and protein-protein similarity graphs but process them independently, limiting their ability to model interdependencies between modalities. Moving beyond isolated embedding generation from protein and drug graphs, we propose DCGAT-DTI, a novel deep learning framework with a dynamic cross-graph attention (DCGAT) module that dynamically models intra- and cross-graph interactions. Initial embeddings are generated using pretrained language models. Similarity graphs constructed from these embeddings are passed to DCGAT, which uses a Graph Convolutional Network-based Cross-Neighborhood Selection network to dynamically select cross-modal neighbors. This allows drug and protein embeddings to incorporate information from both modalities through intra- and cross-graph attention mechanisms. Results: Extensive evaluations on four benchmark datasets demonstrate that DCGAT-DTI outperforms state-of-the-art methods across warm and cold start splits for both balanced and unbalanced datasets. In the challenging unbalanced cold start scenarios, it achieves significant improvement in performance for both drugs and proteins over the baselines. Availability and implementation: Source code is available at https://github.com/compbiolabucf/DCGAT-DTI.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.